Cardiometabolic Syndrome
55
17
18
22
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
1 terminated out of 55 trials
95.7%
+9.1% vs benchmark
2%
1 trials in Phase 3/4
14%
3 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 22 completed trials
Clinical Trials (55)
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
Circadian Intervention to Improve Cardiometabolic Health
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
Impact of Yo-Yo Sleep on Cardiometabolic Health
The Mom and Infant Outcomes (MOMI) Study
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS)
RE-inventing Strategies for Healthy Ageing; Recommendations and Tools
Effects of Berberine on Cardiometabolic Outcomes
Spinal Cord Injury Model Systems (SCIMS) - Education Module
Establishing Clinical Utility Evidence for Chronic Disease Management Testing
Effects of Quercetin on Cardiometabolic Outcomes
The Role of Ectopic Fat and Heart Attack Risk in HIV
FEAST Perinatal Support Program Intervention
Effect of Interrupting Sedentary Time With Different Frequencies of Physical Activity on Cardiometabolic Risk Factors
PDE3B in Metabolic Regulation
Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity
Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot Study
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico